Platelet Functions are Decreased in Obesity and Restored after Weight Loss: Evidence for a Role of the SERCA3-Dependent ADP Secretion Pathway

Ziane Elaïb; Jose Javier Lopez; Muriel Coupaye; Kevin Zuber; Yann Becker; Aurélie Kondratieff; Christelle Repérant; Marion Pépin; Laurence Salomon; France Teillet; Simon Msika; Cécile V. Denis; Dominique de Prost; Jean-Philippe Rosa; Régis Bobe; Alain Stépanian

doi:10.1055/s-0038-1677033

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2019; 119(03): 384-396
DOI: 10.1055/s-0038-1677033

Cellular Haemostasis and Platelets

Georg Thieme Verlag KG Stuttgart · New York

Platelet Functions are Decreased in Obesity and Restored after Weight Loss: Evidence for a Role of the SERCA3-Dependent ADP Secretion Pathway

Autor*innen

Ziane Elaïb^*

¹INSERM Unité Mixte de Recherche–Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France
Jose Javier Lopez^*

¹INSERM Unité Mixte de Recherche–Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France

²Departamento de Fisiología, Catedrático de Universidad, Universidad de Extremadura, Cáceres, Spain
Muriel Coupaye

³Service des Explorations Fonctionnelles, Hôpital Louis Mourier, Assistance Publique–Hôpitaux de Paris, Colombes, France

⁴Centre Intégré Nord Francilien de prise en charge de l'Obésité (CINFO), Paris, France
Kevin Zuber

⁵Service de Recherche Clinique, Fondation Ophtalmologique A. de Rothschild, Paris, France
Yann Becker

¹INSERM Unité Mixte de Recherche–Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France
Aurélie Kondratieff

¹INSERM Unité Mixte de Recherche–Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France
Christelle Repérant

¹INSERM Unité Mixte de Recherche–Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France
Marion Pépin

¹INSERM Unité Mixte de Recherche–Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France
Laurence Salomon

⁵Service de Recherche Clinique, Fondation Ophtalmologique A. de Rothschild, Paris, France

⁶Département de Santé Publique, Hôpital Louis Mourier, Assistance Publique–Hôpitaux de Paris, Colombes, France
France Teillet

⁷Service d'Hématologie et Transfusion, Hôpital Louis Mourier, Assistance Publique–Hôpitaux de Paris, Colombes, France

⁸Université Paris Diderot, Sorbonne Paris Cité, Paris, France
Simon Msika

⁸Université Paris Diderot, Sorbonne Paris Cité, Paris, France

⁹Service de Chirurgie Digestive, Hôpital Louis Mourier, Assistance Publique–Hôpitaux de Paris, Colombes, France
Cécile V. Denis

¹INSERM Unité Mixte de Recherche–Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France
Dominique de Prost

⁷Service d'Hématologie et Transfusion, Hôpital Louis Mourier, Assistance Publique–Hôpitaux de Paris, Colombes, France

⁸Université Paris Diderot, Sorbonne Paris Cité, Paris, France
Jean-Philippe Rosa

¹INSERM Unité Mixte de Recherche–Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France
Régis Bobe^**

¹INSERM Unité Mixte de Recherche–Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France
Alain Stépanian^**

⁸Université Paris Diderot, Sorbonne Paris Cité, Paris, France

¹⁰Service d'Hématologie Biologique, Hôpital Lariboisière, Assistance Publique–Hôpitaux de Paris, Paris, France

¹¹EA3515 Institut Universitaire d'Hématologie, Hôpital Saint Louis, Paris-Diderot, Paris, France

Abstract

In obesity, platelets are described as hyperactive, mainly based on increased platelet size and presence of pro-thrombotic plasmatic molecules. We explored platelet functions, including calcium signalling in obesity, and the effect of weight loss. We included 40 obese patients (women with body mass index [BMI] of ≥ 35 kg/m²) who were to undergo gastric bypass surgery and 40 healthy lean subjects (women with BMI of < 25 kg/m²) as a control group. Approximately 1 year after surgery, the obese patients lost weight (75% had a BMI < 35 kg/m²). They were explored a second time with the same healthy control for the same platelet experiments. Compared with controls, obese patients' platelets displayed reduced sensitivity to thrombin (aggregation EC₅₀ increased by 1.9 ± 0.3-fold, p = 0.005) and a lower Ca²⁺ response (70 ± 7% decrease, p < 10⁻⁴). In 17 pairs of patients, we performed additional experiments: in obese patients' platelets, thrombin-induced αIIbβ3 activation was significantly lower (p = 0.003) and sarco-endoplasmic reticulum Ca²⁺ATPase (SERCA3) expression was decreased (48 ± 6% decrease, p < 10⁻⁴). These differences were abolished after weight loss. Interestingly, pharmacological inhibition of SERCA3 activity in control group's platelets mimicked similar alterations than in obese patients' platelets and was associated with defective adenosine diphosphate (ADP) secretion. Addition of ADP to agonist restored platelet functions in obese patients and in SERCA3-inhibited control platelets (five experiments) confirming the direct involvement of the SERCA3-dependent ADP secretion pathway. This is the first study demonstrating that platelets from obese patients are hypo-reactive, due to a deficiency of SERCA3-dependent ADP secretion. Weight loss restores SERCA3 activity and subsequent calcium signalling, αIIbβ3 activation, platelet aggregation and ADP secretion.

Keywords

platelets - obesity - SERCA3 - bariatric surgery - calcium

Volltext

Referenzen

References
1 Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444 (7121): 875-880
2 World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation; 2000. WHO Technical Report Series 894
3 World Health Organization Fact Sheet N311. Obesity and overweight; 2018
4 Wolk R, Berger P, Lennon RJ, Brilakis ES, Somers VK. Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation 2003; 108 (18) 2206-2211
5 Yusuf S, Hawken S, Ounpuu S. , et al; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366 (9497): 1640-1649
6 Rexrode KM, Hennekens CH, Willett WC. , et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997; 277 (19) 1539-1545
7 Suk SH, Sacco RL, Boden-Albala B. , et al; Northern Manhattan Stroke Study. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 2003; 34 (07) 1586-1592
8 Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med 2005; 118 (09) 978-980
9 Parkin L, Sweetland S, Balkwill A, Green J, Reeves G, Beral V. ; Million Women Study Collaborators. Body mass index, surgery, and risk of venous thromboembolism in middle-aged women: a cohort study. Circulation 2012; 125 (15) 1897-1904
10 Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Curr Opin Hematol 2013; 20 (05) 437-444
11 Anfossi G, Russo I, Trovati M. Platelet dysfunction in central obesity. Nutr Metab Cardiovasc Dis 2009; 19 (06) 440-449
12 Santilli F, Vazzana N, Liani R, Guagnano MT, Davì G. Platelet activation in obesity and metabolic syndrome. Obes Rev 2012; 13 (01) 27-42
13 Santilli F, Simeone P, Liani R, Davì G. Platelets and diabetes mellitus. Prostaglandins Other Lipid Mediat 2015; 120: 28-39
14 Papp B, Enyedi A, Pászty K. , et al. Simultaneous presence of two distinct endoplasmic-reticulum-type calcium-pump isoforms in human cells. Characterization by radio-immunoblotting and inhibition by 2,5-di-(t-butyl)-1,4-benzohydroquinone. Biochem J 1992; 288 (Pt 1): 297-302
15 Brini M, Carafoli E. Calcium pumps in health and disease. Physiol Rev 2009; 89 (04) 1341-1378
16 Elaïb Z, Adam F, Berrou E. , et al. Full activation of mouse platelets requires ADP secretion regulated by SERCA3 ATPase-dependent calcium stores. Blood 2016; 128 (08) 1129-1138
17 López JJ, Redondo PC, Salido GM, Pariente JA, Rosado JA. Two distinct Ca2+ compartments show differential sensitivity to thrombin, ADP and vasopressin in human platelets. Cell Signal 2006; 18 (03) 373-381
18 López JJ, Camello-Almaraz C, Pariente JA, Salido GM, Rosado JA. Ca2+ accumulation into acidic organelles mediated by Ca2+- and vacuolar H+-ATPases in human platelets. Biochem J 2005; 390 (Pt 1): 243-252
19 Angiolillo DJ, Fernández-Ortiz A, Bernardo E. , et al. Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted?. J Invasive Cardiol 2004; 16 (04) 169-174
20 Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003; 115 (Suppl 8A): 37S-41S
21 Beavers CJ, Heron P, Smyth SS, Bain JA, Macaulay TE. Obesity and antiplatelets-does one size fit all?. Thromb Res 2015; 136 (04) 712-716
22 Stepanian A, Bourguignat L, Hennou S. , et al. Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive weight loss. Obesity (Silver Spring) 2013; 21 (11) 2236-2243
23 Dellas C, Schäfer K, Rohm I. , et al. Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity. Thromb Haemost 2008; 100 (06) 1123-1129
24 Varadi A, Lebel L, Hashim Y, Mehta Z, Ashcroft SJ, Turner R. Sequence variants of the sarco(endo)plasmic reticulum Ca(2+)-transport ATPase 3 gene (SERCA3) in Caucasian type II diabetic patients (UK Prospective Diabetes Study 48). Diabetologia 1999; 42 (10) 1240-1243
25 Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010; 140 (06) 900-917
26 Fu S, Yang L, Li P. , et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 2011; 473 (7348): 528-531
27 Li SY, Yang X, Ceylan-Isik AF, Du M, Sreejayan N, Ren J. Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch. Diabetologia 2006; 49 (06) 1434-1446
28 Wu ZK, Wang JJ, Wang T. , et al. Clopidogrel resistance response in patients with coronary artery disease and metabolic syndrome: the role of hyperglycemia and obesity. J Geriatr Cardiol 2015; 12 (04) 378-382
29 Darlington A, Tello-Montoliu A, Rollini F. , et al. Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease. Thromb Haemost 2014; 111 (02) 258-265
30 Norgard NB, Monte SV. Obesity and inflammation and altered clopidogrel pharmacokinetics and pharmacodynamics. Drug Metab Lett 2017; 11 (01) 3-13
31 Haas S, Hansson J, Klimmeck D. , et al. Inflammation-induced emergency megakaryopoiesis driven by hematopoietic stem cell-like megakaryocyte progenitors. Cell Stem Cell 2015; 17 (04) 422-434
32 Nurden P, Debili N, Vainchenker W. , et al. Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia. Blood 2006; 108 (08) 2587-2595
33 Mountian I, Manolopoulos VG, De Smedt H, Parys JB, Missiaen L, Wuytack F. Expression patterns of sarco/endoplasmic reticulum Ca(2+)-ATPase and inositol 1,4,5-trisphosphate receptor isoforms in vascular endothelial cells. Cell Calcium 1999; 25 (05) 371-380
34 Lipskaia L, Hulot JS, Lompré AM. Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation. Pflugers Arch 2009; 457 (03) 673-685
35 Raoux L, Moszkowicz D, Vychnevskaia K. , et al. Effect of bariatric surgery-induced weight loss on platelet count and mean platelet volume: a 12-month follow-up study. Obes Surg 2017; 27 (02) 387-393
36 Angiolillo DJ, Fernandez-Ortiz A, Bernardo E. , et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 2007; 49 (14) 1505-1516

Zusatzmaterial

Supplementary Material (PDF) (opens in new window)